TY - JOUR
T1 - Prognostic accuracy of day versus night ambulatory blood pressure
T2 - a cohort study
AU - Boggia, José
AU - Li, Yan
AU - Thijs, Lutgarde
AU - Hansen, Tine W.
AU - Kikuya, Masahiro
AU - Björklund-Bodegård, Kristina
AU - Richart, Tom
AU - Ohkubo, Takayoshi
AU - Kuznetsova, Tatiana
AU - Torp-Pedersen, Christian
AU - Lind, Lars
AU - Ibsen, Hans
AU - Imai, Yutaka
AU - Wang, Jiguang
AU - Sandoya, Edgardo
AU - O'Brien, Eoin
AU - Staessen, Jan A.
N1 - Funding Information:
The European Union (grants IC15-CT98-0329-EPOGH and LSHM-CT-2006-037093); the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium (grants G.0424.03 and G.0575.06); and the Katholieke Universiteit Leuven, Belgium (grants OT/99/28, OT/00/25 and OT/05/49) gave support to the Studies Coordinating Centre. JAS is holder of the Pfizer Chair for Hypertension and Cardiovascular Research. The Danish Heart Foundation (grant 01-2-9-9A-22914), the Beckett Fonden, and the Lundbeck Fonden supported the studies in Copenhagen. The Bilateral Scientific and Technological Collaboration between China and Flanders, Ministry of the Flemish Community, Brussels (grant BIL02/10) supported the fellowship of Y Li in Leuven. The Ministries of Education, Culture, Sports, Science and Technology (grants 15790293, 17790381, 18390192, and 18590587) and of Health, Labour and Welfare (Health Science Research Grants and Medical Technology Evaluation Research Grants), Grant-in-Aid from the Japanese Society for the Promotion of Science (16.54041 and 18.54042), the Japan Atherosclerosis Prevention Fund, the Uehara Memorial Foundation, and the Takeda Medical Research Foundation supported research in Japan. The National Natural Science Foundation of China (grant 30571607), Beijing, China, and the Shanghai Commissions of Science and Technology (the “Rising Star” programme 06QA14043) and Education (the “Dawn” project) supported the JingNing study in China. We thank Sandra Covens, Katrien Staessen, and Renilde Wolfs (Leuven, Belgium) for their expert assistance.
PY - 2007/10/6
Y1 - 2007/10/6
N2 - Background: Few studies have formally compared the predictive value of the blood pressure at night over and beyond the daytime value. We investigated the prognostic significance of the ambulatory blood pressure during night and day and of the night-to-day blood pressure ratio. Methods: We did 24-h blood pressure monitoring in 7458 people (mean age 56·8 years [SD 13·9]) enrolled in prospective population studies in Denmark, Belgium, Japan, Sweden, Uruguay, and China. We calculated multivariate-adjusted hazard ratios for daytime and night-time blood pressure and the systolic night-to-day ratio, while adjusting for cohort and cardiovascular risk factors. Findings: Median follow-up was 9·6 years (5th to 95th percentile 2·5-13·7). Adjusted for daytime blood pressure, night-time blood pressure predicted total (n=983; p<0·0001), cardiovascular (n=387; p<0·01), and non-cardiovascular (n=560; p<0·001) mortality. Conversely, adjusted for night-time blood pressure, daytime blood pressure predicted only non-cardiovascular mortality (p<0·05), with lower blood pressure levels being associated with increased risk. Both daytime and night-time blood pressure consistently predicted all cardiovascular events (n=943; p<0·05) and stroke (n=420; p<0·01). Adjusted for night-time blood pressure, daytime blood pressure lost prognostic significance only for cardiac events (n=525; p≥0·07). Adjusted for the 24-h blood pressure, night-to-day ratio predicted mortality, but not fatal combined with non-fatal events. Antihypertensive drug treatment removed the significant association between cardiovascular events and the daytime blood pressure. Participants with systolic night-to-day ratio value of 1 or more were older, at higher risk of death, and died at an older age than those whose night-to-day ratio was normal (≥0·80 to <0·90). Interpretation: In contrast to commonly held views, daytime blood pressure adjusted for night-time blood pressure predicts fatal combined with non-fatal cardiovascular events, except in treated patients, in whom antihypertensive drugs might reduce blood pressure during the day, but not at night. The increased mortality in patients with higher night-time than daytime blood pressure probably indicates reverse causality. Our findings support recording the ambulatory blood pressure during the whole day.
AB - Background: Few studies have formally compared the predictive value of the blood pressure at night over and beyond the daytime value. We investigated the prognostic significance of the ambulatory blood pressure during night and day and of the night-to-day blood pressure ratio. Methods: We did 24-h blood pressure monitoring in 7458 people (mean age 56·8 years [SD 13·9]) enrolled in prospective population studies in Denmark, Belgium, Japan, Sweden, Uruguay, and China. We calculated multivariate-adjusted hazard ratios for daytime and night-time blood pressure and the systolic night-to-day ratio, while adjusting for cohort and cardiovascular risk factors. Findings: Median follow-up was 9·6 years (5th to 95th percentile 2·5-13·7). Adjusted for daytime blood pressure, night-time blood pressure predicted total (n=983; p<0·0001), cardiovascular (n=387; p<0·01), and non-cardiovascular (n=560; p<0·001) mortality. Conversely, adjusted for night-time blood pressure, daytime blood pressure predicted only non-cardiovascular mortality (p<0·05), with lower blood pressure levels being associated with increased risk. Both daytime and night-time blood pressure consistently predicted all cardiovascular events (n=943; p<0·05) and stroke (n=420; p<0·01). Adjusted for night-time blood pressure, daytime blood pressure lost prognostic significance only for cardiac events (n=525; p≥0·07). Adjusted for the 24-h blood pressure, night-to-day ratio predicted mortality, but not fatal combined with non-fatal events. Antihypertensive drug treatment removed the significant association between cardiovascular events and the daytime blood pressure. Participants with systolic night-to-day ratio value of 1 or more were older, at higher risk of death, and died at an older age than those whose night-to-day ratio was normal (≥0·80 to <0·90). Interpretation: In contrast to commonly held views, daytime blood pressure adjusted for night-time blood pressure predicts fatal combined with non-fatal cardiovascular events, except in treated patients, in whom antihypertensive drugs might reduce blood pressure during the day, but not at night. The increased mortality in patients with higher night-time than daytime blood pressure probably indicates reverse causality. Our findings support recording the ambulatory blood pressure during the whole day.
UR - http://www.scopus.com/inward/record.url?scp=34848883594&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34848883594&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(07)61538-4
DO - 10.1016/S0140-6736(07)61538-4
M3 - Article
C2 - 17920917
AN - SCOPUS:34848883594
SN - 0140-6736
VL - 370
SP - 1219
EP - 1229
JO - The Lancet
JF - The Lancet
IS - 9594
ER -